Raymond James Financial Services Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-17,100
Closed -$135K 2492
2016
Q3
$135K Buy
+17,100
New +$953K ﹤0.01% 2116

Raymond James Financial Services Advisors's KITE Position: Q4 2017 in Review

Raymond James Financial Services Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,408 shares — an estimated $253K sold.

Raymond James Financial Services Advisors first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $1.19M in Q3 2016. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Raymond James Financial Services Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1,408 Kite Pharma, Inc. shares in Q4 2017, an estimated $253K.
  • Raymond James Financial Services Advisors first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
  • Raymond James Financial Services Advisors's Kite Pharma, Inc. position peaked at $1.19M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.